PNC Financial Services Group
ANVS icon

PNC Financial Services Group’s Annovis Bio ANVS Stock Holding History

PNC Financial Services Group’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$803 Hold
360
– – ﹤0.01% 4806
2025
Q4 		$1.25K Hold
360
– – ﹤0.01% 4643
2025
Q3 		$745 Hold
360
– – ﹤0.01% 4732
2025
Q2 		$781 Hold
360
– – ﹤0.01% 4601
2025
Q1 		$540 Buy
+360
New +$1.1K ﹤0.01% 4628

Other funds holding ANVS

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

PNC Financial Services Group's ANVS Position: Q1 2026 in Review

PNC Financial Services Group held its Annovis Bio (ANVS) position steady in Q1 2026 at 360 shares worth $803. The position accounts for ﹤0.01% of the portfolio, ranked #4806.

PNC Financial Services Group first reported a position in ANVS in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.25K in Q4 2025. 56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.

  • PNC Financial Services Group held 360 shares of Annovis Bio worth $803 as of Q1 2026.
  • PNC Financial Services Group left its Annovis Bio share count unchanged in Q1 2026.
  • Annovis Bio made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4806 holding.
  • PNC Financial Services Group first reported a position in Annovis Bio in Q1 2025 and has held it in 5 quarters since.
  • PNC Financial Services Group's Annovis Bio position peaked at $1.25K in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.